HCA Healthcare, Inc. $HCA Shares Bought by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 14.6% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 16,106 shares of the company’s stock after purchasing an additional 2,049 shares during the quarter. Motley Fool Asset Management LLC’s holdings in HCA Healthcare were worth $6,170,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Cheviot Value Management LLC acquired a new position in shares of HCA Healthcare during the first quarter valued at $26,000. Saudi Central Bank acquired a new position in shares of HCA Healthcare during the first quarter valued at $26,000. WPG Advisers LLC acquired a new stake in HCA Healthcare in the first quarter worth about $27,000. Ameriflex Group Inc. acquired a new stake in HCA Healthcare in the second quarter worth about $27,000. Finally, Chung Wu Investment Group LLC acquired a new stake in HCA Healthcare in the second quarter worth about $27,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Trading Up 4.8%

NYSE HCA opened at $468.68 on Tuesday. The stock’s 50-day moving average price is $416.33 and its two-hundred day moving average price is $383.23. The company has a market cap of $109.67 billion, a PE ratio of 18.12, a PEG ratio of 1.41 and a beta of 1.40. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $469.18.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 11.13%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on HCA shares. Mizuho upped their price objective on shares of HCA Healthcare from $475.00 to $505.00 and gave the stock an “outperform” rating in a report on Monday. Royal Bank Of Canada upped their price objective on shares of HCA Healthcare from $449.00 to $482.00 and gave the stock an “outperform” rating in a report on Monday. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $417.00 price objective on shares of HCA Healthcare in a research note on Monday. Weiss Ratings restated a “buy (b-)” rating on shares of HCA Healthcare in a report on Wednesday, October 8th. Finally, KeyCorp increased their price objective on HCA Healthcare from $465.00 to $475.00 and gave the company an “overweight” rating in a research report on Monday. Thirteen investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $471.42.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.